Form 4: Sight Sciences CTO Sells Shares for Tax Obligations

Sight Sciences' Chief Technology Officer, David Badawi, sold 9,660 shares of common stock across three transactions in early January 2026 to cover tax liabilities from restricted stock unit vesting.

Summary

• David Badawi, Chief Technology Officer and Director of Sight Sciences, Inc. (SGHT), reported three separate sales of common stock.
• On January 2, 2026, 2,914 shares were sold at a weighted average price of $7.43 per share, with prices ranging from $7.29 to $8.07.
• On January 5, 2026, 3,051 shares were sold at a weighted average price of $7.82 per share, with prices ranging from $7.71 to $7.97.
• On January 6, 2026, 3,695 shares were sold at a weighted average price of $7.48 per share, with prices ranging from $7.39 to $7.67.
• The total number of shares sold across these transactions was 9,660.
• These sales were conducted to cover the reporting person's tax liability in connection with the vesting of restricted stock units.
• Following these transactions, David Badawi beneficially owns 1,917,109 shares of common stock directly.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.

Sentiment

Score: 5

Explanation: The filing reports routine insider stock sales to cover tax obligations, which is a common and neutral event.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This filing is specific to an individual insider's transactions and does not provide broader industry context or trends.

Stakeholder Impact

• Minimal direct impact on shareholders as these are routine tax-related sales by an insider, typically not indicative of a change in company fundamentals or management confidence.

Key Dates

Recommendation

The filing details routine insider stock sales by the Chief Technology Officer to cover tax liabilities from RSU vesting. These transactions are common and do not typically signal a change in the company's fundamentals or management's confidence, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Sight Sciences, SGHT, Insider Trading, Form 4, Stock Sale, David Badawi, CTO, Restricted Stock Units, Tax Liability